You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 15, 2025

Drug Price Trends for DOCOSANOL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DOCOSANOL

Average Pharmacy Cost for DOCOSANOL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DOCOSANOL 10% CREAM 61269-0989-37 6.02291 GM 2025-02-19
DOCOSANOL 10% CREAM 70000-0517-01 6.02291 GM 2025-02-19
DOCOSANOL 10% CREAM 00536-1379-04 6.02291 GM 2025-02-19
DOCOSANOL 10% CREAM 61269-0981-35 6.02291 GM 2025-02-19
DOCOSANOL 10% CREAM 00713-0353-02 6.02291 GM 2025-02-19
DOCOSANOL 10% CREAM 00713-0353-62 6.02291 GM 2025-02-19
DOCOSANOL 10% CREAM 61269-0981-35 5.91398 GM 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Docosanol

Introduction to Docosanol

Docosanol, a saturated monofatty alcohol, is widely used as a topical treatment for cold sores and fever blisters caused by the herpes simplex virus (HSV). It is available over-the-counter and has become a staple in the treatment of these common viral infections.

Global Market Overview

The global Docosanol Cream market is experiencing significant growth, driven by several key factors. Here are some key points to consider:

  • Market Size and Growth: The global Docosanol Cream market was valued at approximately $1.6 billion in 2021 and is projected to grow at a remarkable CAGR during the forecast period from 2023 to 2030[4][5].
  • Regional Segmentation: The market is segmented geographically into North America, Europe, Asia Pacific, and the rest of the world. Each region is analyzed in terms of sales volume and revenue, providing a comprehensive view of the market's global reach[1][4][5].

Market Drivers

Several factors are driving the growth of the Docosanol Cream market:

  • High Prevalence of HSV Infection: The increasing prevalence of HSV infections globally is a major driver. HSV infections can lead to significant complications such as encephalitis and keratitis, especially in individuals with chronic conditions[3].
  • Healthcare Infrastructure and Expenditure: Rising healthcare expenditure and improvements in healthcare infrastructure are also contributing to the market's growth. Government initiatives to enhance healthcare facilities and awareness campaigns further support this trend[3][4].
  • Increasing Disposable Income: The growing disposable income and favorable government initiatives are additional factors boosting the market's expansion[3][4].

Market Segmentation

The Docosanol Cream market is segmented based on several criteria:

  • Type: The market is segmented into online and offline sales channels. This segmentation helps in understanding the distribution and sales strategies of the product[5].
  • Application: The primary applications are the treatment of cold sores and fever blisters. This segmentation highlights the specific use cases and demand drivers for Docosanol Cream[5].
  • Geography: The market is divided into North America, Europe, Asia Pacific, and the rest of the world. This geographical segmentation provides insights into regional market sizes, sales, and revenue[1][4][5].

Competitive Landscape

The competitive landscape of the Docosanol Cream market is characterized by several key players:

  • Major Players: Companies such as Aleorderm, Glaxo Smith Kline, Jenson Pharmaceutical Services, and PL Developments are prominent in the market. These companies are profiled in detail, including their market entry year and product offerings[4][5].
  • Market Share and Ranks: The report provides profiles of the competitive landscape, key competitors, and their respective market ranks. This helps in assessing the market competitive situation and making informed business decisions[1].

Price Projections and Retail Prices

The retail prices of Docosanol Cream vary based on the pharmacy and the presence of discount cards:

  • Retail Prices: Without insurance, the average retail price of Docosanol Cream is around $26.26. However, with discount cards like those from SingleCare, the price can be reduced significantly, to as low as $12.13[2].
  • Price Trends: The global sales market share and revenue market share by type and application are expected to show steady growth. The price per unit (US$/Box) by type is also projected to remain stable or see slight increases due to market demand and competition[1].

Technological Trends and New Product Developments

The market is also influenced by technological trends and new product developments:

  • New Medications: The lack of effective drugs for cold sore treatment presents opportunities for pharmaceutical companies to develop new medications. This involves incorporating new technologies to isolate molecules for treatment and optimizing pharmacokinetics and pharmacodynamics[3][4].
  • Emerging Markets: Investments in advanced technologies and the expansion into emerging markets are additional factors driving the market's growth[3].

Challenges and Restraints

Despite the growth, the market faces some challenges:

  • High Cost Associated with Treatment: One of the significant restraints is the high cost associated with the treatment of cold sores and fever blisters. This can limit access to the medication, especially in regions with lower healthcare expenditure[3].

Regional Market Analysis

The market is analyzed regionally to provide a detailed understanding of its performance:

  • North America: This region includes the United States, Canada, and other countries. The market size, sales, and revenue by country are provided to give a comprehensive view of the regional market[1].
  • Europe: Countries such as Germany, France, the U.K., Italy, and Russia are analyzed in terms of market size, sales, and revenue[1].
  • Asia Pacific: This region includes China, Japan, South Korea, India, Australia, and Southeast Asia. The market dynamics in these countries are crucial for understanding the global market's growth[1].
  • Latin America and Middle East & Africa: These regions are also analyzed to provide a complete global perspective on the market[1].

Key Takeaways

  • The global Docosanol Cream market is expected to grow significantly due to the high prevalence of HSV infections and improvements in healthcare infrastructure.
  • The market is segmented by type, application, and geography, providing a detailed understanding of its dynamics.
  • Major players such as Aleorderm, Glaxo Smith Kline, and Jenson Pharmaceutical Services are driving the market forward.
  • Retail prices vary, but discount cards can significantly reduce the cost.
  • Technological advancements and new product developments are key drivers of market growth.

FAQs

Q: What is Docosanol used for? A: Docosanol is used as a topical treatment for cold sores and fever blisters caused by the herpes simplex virus (HSV)[2].

Q: What is the current market size of the Docosanol Cream market? A: The global Docosanol Cream market was valued at approximately $1.6 billion in 2021[4].

Q: Who are the major players in the Docosanol Cream market? A: Major players include Aleorderm, Glaxo Smith Kline, Jenson Pharmaceutical Services, and PL Developments[4][5].

Q: How can I reduce the cost of Docosanol Cream? A: Using discount cards like those from SingleCare can reduce the price of Docosanol Cream significantly[2].

Q: What are the main drivers of the Docosanol Cream market growth? A: The high prevalence of HSV infections, improvements in healthcare infrastructure, and increasing disposable income are key drivers[3][4].

Cited Sources

  1. Global Docosanol Cream Market Research Report 2024 - QY Research
  2. Docosanol Coupons & Prices - SingleCare
  3. Cold Sore Treatment Market Size & Industry Statistics By 2030 - Data Bridge Market Research
  4. Docosanol Cream Market Size, Share, Scope, Trends And Forecast - Verified Market Reports
  5. Global Docosanol Cream Market Size, Trends and Projections - Market Research Intellect

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.